Nursing management of the patient receiving Taxol therapy.

Taxol is an important new antitumor agent with demonstrated efficacy in ovarian and breast cancer. Toxicities identified, including cardiac, hypersensitivity reactions, and neurologic, require careful nursing assessment for management, Additional toxicities may be identified as Taxol is combined with other chemotherapeutic agents. Studies to determine the most effective dose and schedule are ongoing. The current evaluation of this new drug presents an important opportunity for nurses to contribute to its development through both clinical and research endeavors. Such contributions will facilitate the optimal nursing care of patients treated with Taxol.
AuthorsM H Noone, M S McCabe, A M Denicoff, J M Lepore
JournalJournal of the National Cancer Institute. Monographs (J Natl Cancer Inst Monogr) Issue 15 Pg. 149-54 ( 1993) ISSN: 1052-6773 [Print] UNITED STATES
PMID7912521 (Publication Type: Journal Article, Review)
Chemical References
  • Paclitaxel
  • Humans
  • Neoplasms (drug therapy, nursing)
  • Nursing Assessment
  • Paclitaxel (adverse effects, therapeutic use)
  • Patient Education as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password:
Type Validation Code Shown: